¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"1"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 3
17-HCS 17-hydroxycorticosteroid
17-K 17-ketosteroid
17-KGS 17-ketogenic steroid
17-KS 17-Keto-Steroid
17-KS 17-Keto-Steroid
17-KS 17-ketosteroid
17-KSR 17-ketosteroid reductase
17-OH 17-hydroxycorticosteroid
17-OHCS 17-OH(Hydroxy)-Corticosteroid
17-OHP 17-hydroxyprogesterone
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 10 ÆäÀÌÁö: 3
1,25-(OH)2D3 1 ,25-Dihydroxyvitamin D3
1,25-D 1, 25-dihydroxy vitamin D
1,25-D3 1 alpha, 25-Dihydroxyvitamin D3
1,3-DMU 1,3 dimethyluric acid
1,3-DNB 1,3-Dinitrobenzene
1,4 DHP 1,4 dihydropyridine
1,4,5-IP3 1,4,5-triphosphate
1,5AG 1,5 anhydroglucitol
1,6-DNP 1,6-Dinitropyrene
1,8-DNP 1,8-Dinitropyrene
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
  • JrId: 1469
    JournalTitle: 1985)
    MedAbbr: Dev Biol (N Y 1985)
    ISSN:
    ESSN:
    IsoAbbr: Dev. Biol. (NY)
    NlmId: 8611888
  • JrId: 1478
    JournalTitle: 1988)
    MedAbbr: Jahresber Schweiz Akad Med Wiss
    ISSN: 1016-1562
    ESSN:
    IsoAbbr:
    NlmId: 8916516
  • JrId: 1553
    JournalTitle: 1986)
    MedAbbr: J Chem Technol Biotechnol
    ISSN: 0268-2575
    ESSN:
    IsoAbbr:
    NlmId: 8711102
  • JrId: 1697
    JournalTitle: 1990)
    MedAbbr: Eur J Cancer
    ISSN: 0959-8049
    ESSN:
    IsoAbbr: Eur. J. Cancer
    NlmId: 9005373
  • JrId: 1719
    JournalTitle: 1987)
    MedAbbr: Acta Radiol
    ISSN: 0284-1851
    ESSN:
    IsoAbbr:
    NlmId: 8706123
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
1-deoxynojirimycin <chemical> (2r-(2 alpha,3 beta,4 alpha,5 beta))-2-(hydroxymethyl)-3,4,5-piperidinetriol. An alpha-glucosidase inhibitor with antiviral action. Derivatives of deoxynojirimycin may have anti-HIV activity.
Pharmacological action: antiviral agents, enzyme inhibitors.
Chemical name: 3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-
(12 Dec 1998)
1-ene-dehydrogenase <enzyme> Converts testosterone to 1-dehydrotestosterone in the absence of nad
Registry number: EC 1.3.-
Synonym: monocresyl diphenyl phosphate
(26 Jun 1999)
1-hexadecanol The 16-carbon alcohol corresponding to palmitic acid, so called because it is isolated from among the hydrolysis products of spermaceti; it is used as an emulsifying aid and in the preparation of "washable" ointment bases.
Synonym: 1-hexadecanol, palmityl alcohol.
(05 Mar 2000)
1-methyl-3-isobutylxanthine <chemical> 3,7-dihydro-1-methyl-3-(2-methylpropyl)-1h-purine-2,6-dione. A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates cyclic nucleotide-dependent protein kinases.
Pharmacological action: phosphodiesterase inhibitors.
Chemical name: 1H-Purine-2,6-dione, 3,7-dihydro-1-methyl-3-(2-methylpropyl)-
(12 Dec 1998)
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine <chemical> 1,2,3,6-tetrahydro-1-methyl-4-phenylpyridine. A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in parkinson disease. These toxic effects can be prevented by the administration of selective monoamine oxidase inhibitors. Since the cellular toxicity of the compound is similar to that observed in idiopathic parkinson disease, experimental studies with this compound can suggest new opportunities for effective therapy. The compound also induces duodenal ulcers.
Pharmacological action: dopamine agents.
Chemical name: Pyridine, 1,2,3,6-tetrahydro-1-methyl-4-phenyl-
(12 Dec 1998)
1-methyl-4-phenylpyridinium <chemical> 1-methyl-4-phenylpyridinium (mpp+). An active neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp). The compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. These and other toxic effects lead to cessation of oxidative phosphorylation, ATP depletion, and cell death. The compound, which is related to paraquat, has also been used as an herbicide.
Pharmacological action: dopamine agents, herbicides.
Chemical name: Pyridinium, 1-methyl-4-phenyl-
(12 Dec 1998)
1-naphthylamine <chemical> 1-naphthalenamine. A suspected industrial carcinogen (and listed as such by osha). Its n-hydroxy metabolite is strongly carcinogenic and mutagenic.
Pharmacological action: carcinogens.
Chemical name: 1-Naphthalenamine
(12 Dec 1998)
1-naphthylisothiocyanate <chemical> 1-isothiocyanatonaphthalene. A tool for the study of liver damage which causes bile stasis and hyperbilirubinaemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. It may cause skin and kidney damage.
Chemical name: Naphthalene, 1-isothiocyanato-
(12 Dec 1998)
1-nitropyrene reductase <enzyme> Nadh or NADPH can serve as reducing agent to form 1-aminopyrene
Registry number: EC 1.7.-
Synonym: 1-nitropyrene nitroreductase
(26 Jun 1999)
1-O-alkyl-2-acyl-sn-glycero-3-phosphorylethanolamine desaturase <enzyme> Alkylacylglycerophosphorylethanolamine alk-1-enylacyl-glycerophosphorylethanolamine (ethanolamine plasmalogen) type of reaction (cis-olefination), cofactor requirement resembles fatty acid desaturases
Registry number: EC 1.14.99.-
(26 Jun 1999)
1-octanol <chemical> A colourless, slightly viscous liquid used as a defoaming or wetting agent. It is also used as a solvent for protective coatings, waxes, and oils, and as a raw material for plasticisers.
Pharmacological action: solvents.
(12 Dec 1998)
1-phosphatidylinositol 3-kinase <enzyme> An enzyme that catalyses the conversion of phosphatidylinositol to phosphatidylinositol 3-phosphate. This is the first committed step in the biosynthesis of phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate. This pathway is thought to play a critical role in DNA repair, v(d)j recombination and cell cyle checkpoints.37.
Chemical name: ATP:1-phosphatidyl-1D-myo-inositol 3-phosphotransferase
Registry number: EC 2.7.1.137
(12 Dec 1998)
1-phosphatidylinositol 4-kinase <enzyme> An enzyme that catalyses the conversion of phosphatidylinositol to phosphatidylinositol 4-phosphate, the first committed step in the biosynthesis of phosphatidylinositol 4,5-bisphosphate.
Chemical name: ATP:1-phosphatidyl-1D-myo-inositol-4-phosphate
Registry number: EC 2.7.1.67
(12 Dec 1998)
1-phosphofructaldolase <enzyme> An enzyme of the lyase class that catalyses the cleavage of fructose 1,6-biphosphate to form dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. The enzyme also acts on (3s,4r)-ketose 1-phosphates. The yeast and bacterial enzymes are zinc proteins. (enzyme nomenclature, 1992) e.c. 4.1.2.13.
Chemical name: D-Fructose-1,6-biphosphate D-glyceraldehyde-3-phosphate-lyase
Registry number: EC 4.1.2.13
(12 Dec 1998)
1-phosphofructokinase <enzyme> From rhodobacter capsulatus fruk gene; catalyses d-fructose 1-phosphate to yield d-fructose 1,6-bisphosphate in presence of ATP; itp, GTP and utp can replace ATP
Registry number: EC 2.7.1.56
Synonym: fructose 1-phosphate kinase, fruk gene product, phosphofructo-1-kinase
(26 Jun 1999)
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 5 ÆäÀÌÁö: 3
  • 1-Methyl-3-isobutylxanthine - »õâ A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
    Synonyms : IBMX, 1 Methyl 3 isobutylxanthine, 3 Isobutyl 1 methylxanthine
  • 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - »õâ A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
    Synonyms : N-Methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine
  • 1-Methyl-4-phenylpyridinium - »õâ An active neurotoxic metabolite of 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE. The compound reduces dopamine levels, inhibits the biosynthesis of catecholamines, depletes cardiac norepinephrine and inactivates tyrosine hydroxylase. These and other toxic effects lead to cessation of oxidative phosphorylation, ATP depletion, and cell death. The compound, which is related to PARAQUAT, has also been used as an herbicide.
    Synonyms : 1-Methyl-4-phenylpyridine, 1-Methyl-4-phenylpyridinium Chloride, 1-Methyl-4-phenylpyridinium Ion, N-Methyl-4-phenylpyridine, N-Methyl-4-phenylpyridinium, 1 Methyl 4 phenylpyridine, 1 Methyl 4 phenylpyridinium, 1 Methyl 4 phenylpyridinium Chloride
  • 1-Naphthylamine - »õâ A suspected industrial carcinogen (and listed as such by OSHA). Its N-hydroxy metabolite is strongly carcinogenic and mutagenic.
    Synonyms : 8-Aminonaphthalene, Naphthalidine, 1 Aminonaphthalene, 1 Naphthylamine, 8 Aminonaphthalene, alpha Naphthylamine
  • 1-Naphthylisothiocyanate - »õâ A tool for the study of liver damage which causes bile stasis and hyperbilirubinemia acutely and bile duct hyperplasia and biliary cirrhosis chronically, with changes in hepatocyte function. It may cause skin and kidney damage.
    Synonyms : 1 Naphthylisothiocyanate, alpha Naphthylisothiocyanate
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 10 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
ÇϵðÄÝÆÄ¿öÁ¤ - »õâ
±¤µ¿Á¦¾à
1)" target="_blank" class="search11" onfocus="blur()"> °¥±ÙÅÁ¿¢½º(10->1), Acetaminophen, Ascorbic Acid, Caffeine anhydrous, Chlorpheniramine Maleate, Dextromethorphan HBr, Lysozyme Chloride, Pseudoephedrine HCl
ÀϹÝÀǾàǰ | ºñ±Þ¿©
½ºÅäÆÛ¿¡½ºÄ°¼¿ - »õâ
¿µÀÏÁ¦¾à
1)" target="_blank" class="search11" onfocus="blur()"> °¥±ÙÅÁ¿¢½º(10->1), Acetaminophen, Caffeine anhydrous, Chlorpheniramine Maleate, Dextromethorphan HBr, Potassium guaiacol sulfonate
ÀϹÝÀǾàǰ | ºñ±Þ¿©
ÃÊÀ̽ºÄÝݼ¿ - »õâ
´ëÇÑ´ºÆÊ
1)" target="_blank" class="search11" onfocus="blur()"> °¥±ÙÅÁ¿¢½º(10->1), Acetaminophen, Chlorpheniramine Maleate, Dextromethorphan HBr, Lysozyme Chloride, Pseudoephedrine HCl
ÀϹÝÀǾàǰ | ºñ±Þ¿©
¾ÆÅõºó¿¡ÇÁݼ¿ - »õâ
´ë¿ì¾àǰ°ø¾÷
1)" target="_blank" class="search11" onfocus="blur()"> °¥±ÙÅÁ¿¢½º(10->1), Acetaminophen, Ascorbic Acid, Caffeine anhydrous, Chlorpheniramine Maleate, Cloperastine HCl, Lysozyme Chloride, Phenylpropanolamine HCl, Riboflavin, Thiamine nitrate
ÀϹÝÀǾàǰ | »èÁ¦
10%Çí½º·Î½ÇÁÖ - »õâ
´ëÇѾàǰ°ø¾÷
A02704231 Hydroxyethyl starch, Sodium Chloride
Àü¹®ÀǾàǰ | »èÁ¦
ÄÞºñ·¹¹Ù¿¬Áúĸ½¶ - »õâ
ȯÀÎÁ¦¾à
1)" target="_blank" class="search11" onfocus="blur()"> Ginseng dried extract(6.7->1), Inositol, Taurine, Thiamine nitrate, Ursodesoxycholic Acid
ÀϹÝÀǾàǰ | ºñ±Þ¿©
°¥±ÝÅÁÁ¤ - »õâ
¾¾Æ®¸®
A13851301 1)" target="_blank" class="search11" onfocus="blur()"> °¥±ÙÅÁ¿¢½º(10->1), Acetaminophen, Ascorbic Acid, Chlorpheniramine Maleate, Dextromethorphan HBr
ÀϹÝÀǾàǰ | »èÁ¦
Áß¿Ü10%Æ÷µµ´ç°¡0.45%¿°È­³ªÆ®·ýÁÖ - »õâ
Áß¿Ü
A02107121 Glucose, Sodium Chloride
Àü¹®ÀǾàǰ | ±Þ¿©
¿¡¹ÙÁ¤(´ë½ÃÈ£ÅÁ°ÇÁ¶¿¢½º) - »õâ
È޿½º
1)" target="_blank" class="search11" onfocus="blur()"> ´ë½ÃÈ£ÅÁ°ÇÁ¶¿¢½º(6.45->1)
ÀϹÝÀǾàǰ | ºñ±Þ¿©
10%Æ÷µµ´ç°¡¿£¿¡ÀÌ.ÄÉÀÌÁÖ3(500ml/¹é) - »õâ
Áß¿Ü
A02107082 Dextrose, Potassium Chloride, Sodium Chloride
Àü¹®ÀǾàǰ | ±Þ¿©
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
18-hydroxylase deficiency corticosterone methyl oxidase deficiency, sometimes used specifically to denote one of the two types.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
18-hydroxysteroid dehydrogenase the enzyme activity of corticosterone 18-monooxygenase specifically catalyzing the second (oxidation) reaction. Deficiency of this enzyme activity is called corticosterone methyl oxidase deficiency, type II.
Ãâó: www.mercksource.com/pp/us/cns/cns_health_library.j...
12-step program A form of treatment, used primarily by persons who abuse alcohol or other substances, that relies on social support, interpersonal motivation, abstinence from the addictive substance, and spirituality.
Ãâó:
17-hydroxycorticosterone Hydrocortisone.
Ãâó:
17-ketosteroid One of a group of neutral steroids having a ketone group in carbon position 17. They are produced by the adrenal cortex and gonads and appear normally in the urine. Among them are androsterone, dehydroisoandrosterone, corticostero
Ãâó:
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 12 ÆäÀÌÁö: 3
1 being one more than ten
1 (formerly in England) an examination taken by 11 and 12 year old students to select suitable candidates for grammar school
1 being ten more than one hundred
1 the ordinal number of one hundred ten in counting order
1 being five more than one hundred ten
1 the ordinal number of one hundred fifteen in counting order
1 coming next after the tenth and just before the twelfth in position
1 the cardinal number that is the sum of eleven and one
1 denoting a quantity consisting of 12 items or units
1 a type of serial music introduced by Arnold Schoenberg
1 a type of serial music introduced by Arnold Schoenberg
1 the cardinal number that is the product of ten and twelve
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á